NCT00360282View on ClinicalTrials.gov

Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

March 31, 2010

Conditions
Migraine
Interventions
DRUG

Rizatriptan

10 mg Rizatriptan in an unlabeled pill given once on one of two visits

OTHER

Placebo

In an unlabeled pill given once on one of two visits.

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT00360282 - Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? | Biotech Hunter | Biotech Hunter